Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

An Age Distribution of D-Dimer Values in Normal Healthy Donor Population: An Indirect Verification of the Age-Adjusted D-Dimer Cutoffs for VTE Exclusion

Rachel Leger, Sandra c Bryant, M.S., Kelly Edwards, Julie I Tange, Kara A Fylling, Deepti M. Warad, M.B.B.S., Rong He, MD, Dong Chen, MD PhD, Rajiv Pruthi, MBBS

Blood (2016) 128 (22): 1432.

https://doi.org/10.1182/blood.V128.22.1432.1432

Published: 2016

Journal Articles

Deep Molecular Response (DMR) in Chronic Myeloid Leukemia (CML) the Tawam Experience

Arif Alam, MBBS, Amar Lal, MD, Hani Y Osman, Sabir Hussain, MD, Donna Lee, Jorgen Kristensen, MD PhD

Blood (2015) 126 (23): 5152.

https://doi.org/10.1182/blood.V126.23.5152.5152

Published: 2015

Journal Articles

Age Distribution and Pattern of Myeloid Marrow Mutations in Patients (pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) after Failure of Hypomethylating Agents (HMAs)

Ghulam J Mufti, FRCP, FRCPath, MD, Lewis R. Silverman, MD, Steven Best, PhD, Steve Fructman, MD, Nozar Azarnia, PhD, Michael E. Petrone, MD MPH, Guillermo Garcia-Manero, MD

Blood (2015) 126 (23): 5257.

https://doi.org/10.1182/blood.V126.23.5257.5257

Published: 2015

Journal Articles

Characterization of the Mutational Spectrum in Young Patients with Myelodysplastic Syndrome

Cassandra M Hirsch, Bartlomiej Przychodzen, MSc, Tomas Radivoyevitch, PhD, Sean Hobson, Bhumika J. Patel, Swapna Thota, MD, Michael J. Clemente, Hetty E. Carraway, MD MBA, Mikkael A Sekeres, MD MS, Jaroslaw P. Maciejewski, MD PhD

Blood (2015) 126 (23): 5218.

https://doi.org/10.1182/blood.V126.23.5218.5218

Published: 2015

Journal Articles

Age Distribution, Side Effects and Co-Occurring Diagnoses, and Duration of Treatment of Multiple Myeloma Patients Receiving Bortezomib or Lenalidomide in Community Oncology Clinics

Jennifer Reichert, PhD, Jeffrey Patton, MD

Blood (2014) 124 (21): 5738.

https://doi.org/10.1182/blood.V124.21.5738.5738

Published: 2014

Journal Articles

CML Patients In Clinical Trials Represent Fairly Well The General Population Of CML Patients: A Comparative Analysis Of 5803 Patients From The EUTOS Registry

Verena S Hoffmann, PhD, Doris Lindoerfer, Dipl.-Inf., Markus Pfirrmann, PhD, Susanne Saussele, MD, Andreas Hochhaus, MD, Jutta Engel, PhD, MD, Joelle Guilhot, PhD, Gianantonio Rosti, Jiri Mayer, MD, PhD, Karel Indrak, MD, Fausto Castagnetti, Anna Turkina, Andrey Zaritskey, MD, PhD, Juan Luis Steegmann, MD, PhD, Andrzej Hellmann, Noortje Thielen, MD, Francisco Cervantes, MD, PhD, Bengt Simonsson, MD, PhD, Adriana Colita, MD, Richard E. Clark, MBBS, MD, FRCP, FRCPath, Antonio Almeida, MD, PhD, Boris Labar, MD, PhD, David Marin, MD, Gert J. Ossenkoppele, MD PhD, Andrija Bogdanovic, Irina Dyagil, Kimmo Porkka, MD, PhD, Stephen O'Brien, Laimonas Griskevicius, Panagiotis Panagiotidis, MD, Josef Thaler, MD, Irena Zupan, MD, PhD, Sandra Lejniece, PhD, MD, Hele Everaus, MD, PhD, Tamás Masszi, MD, PhD, Frederiki Melanthiou, Rüdiger Hehlmann, Joerg Hasford, MD, Michele Baccarani, MD

Blood (2013) 122 (21): 2735.

https://doi.org/10.1182/blood.V122.21.2735.2735

Published: 2013

Journal Articles

CML Management At Tertiary Care Centres in Abu Dhabi, United Arab Emirates

Arif Alam, MBBS, Sabir Hussain, Amar Lal, Imran Mirza, Nameer Al Saadawi, Donna Lee, Jorgen Kristensen, MD, PhD

Blood (2011) 118 (21): 4451.

https://doi.org/10.1182/blood.V118.21.4451.4451

Published: 2011

Journal Articles

Changing Age Distribution of Deep Venous Thrombosis In the United States

Prabhu Viswanathan, MD, Lakshmanan Krishnamurti, MD

Blood (2010) 116 (21): 1539.

https://doi.org/10.1182/blood.V116.21.1539.1539

Published: 2010

Journal Articles

The Age of Mexican Patients with Chronic Myeloid Leukemia (CML) Ph+ Is Quite Younger Than the Reported in USA and European Series.

Pablo Vargas-Viveros, M.D., Rafael Hurtado Monroy, MD, Eduardo Cervera, MD, Carlos Best, M.D., Alvaro Aguayo, M.D., Myrna Candelaria, MD

Blood (2009) 114 (22): 4291.

https://doi.org/10.1182/blood.V114.22.4291.4291

Published: 2009

Journal Articles

Health Related Quality of Life (HRQOL) in Patients Receiving Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) or Fludarabine and Cyclophosphamide (FC) for First Line Therapy with Advanced Chronic Lymphocytic Leukemia (CLL).

Barbara F. Eichhorst, MD, Kirsten Fischer, Anna- Maria Fink, MD, Guenter Fingerle-Rowson, MD, PhD, Anne Westermann, Clemens-Martin Wendtner, MD, Raymonde Busch, Michael Hallek, MD

Blood (2009) 114 (22): 3438.

https://doi.org/10.1182/blood.V114.22.3438.3438

Published: 2009

Journal Articles

Characteristics of Patients with Stage I Follicular Lymphoma (FL) Selected for Watchful Waiting (WW) in the US: Report from the National LymphoCare Study (NLCS).

Jonathan W. Friedberg, Elaine Wong, Michael Taylor, Ming Lin, Mohamed Darif, Hildy Dillon

Blood (2007) 110 (11): 3315.

https://doi.org/10.1182/blood.V110.11.3315.3315

Published: 2007

Journal Articles

AML with 11q23/ MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

Claudia Schoch, Susanne Schnittger, Mirjam Klaus, Wolfgang Kern, Wolfgang Hiddemann, Torsten Haferlach

Blood (2003) 102 (7): 2395–2402.

https://doi.org/10.1182/blood-2003-02-0434

Published: 2003

Journal Articles

Rebuttal to Ajioka and Kushner

Ernest Beutler

Blood (2003) 101 (9): 3354–3357.

https://doi.org/10.1182/blood-2002-12-3926

Published: 2003

Journal Articles

Hodgkin’s Disease : Mortality in the United States, 1921-1951; Race, Sex and Age Distribution; Comparison with Leukemia

MICHAEL B. SHIMKIN

Blood (1955) 10 (12): 1214–1227.

https://doi.org/10.1182/blood.V10.12.1214.1214

Published: 1955

NARROW

An Age Distribution of D-Dimer Values in Normal Healthy Donor Population: An Indirect Verification of the Age-Adjusted D-Dimer Cutoffs for VTE Exclusion

Deep Molecular Response (DMR) in Chronic Myeloid Leukemia (CML) the Tawam Experience

Age Distribution and Pattern of Myeloid Marrow Mutations in Patients (pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS) after Failure of Hypomethylating Agents (HMAs)

Characterization of the Mutational Spectrum in Young Patients with Myelodysplastic Syndrome

Age Distribution, Side Effects and Co-Occurring Diagnoses, and Duration of Treatment of Multiple Myeloma Patients Receiving Bortezomib or Lenalidomide in Community Oncology Clinics

CML Patients In Clinical Trials Represent Fairly Well The General Population Of CML Patients: A Comparative Analysis Of 5803 Patients From The EUTOS Registry

CML Management At Tertiary Care Centres in Abu Dhabi, United Arab Emirates

Changing Age Distribution of Deep Venous Thrombosis In the United States

The Age of Mexican Patients with Chronic Myeloid Leukemia (CML) Ph+ Is Quite Younger Than the Reported in USA and European Series.

Health Related Quality of Life (HRQOL) in Patients Receiving Chemoimmunotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) or Fludarabine and Cyclophosphamide (FC) for First Line Therapy with Advanced Chronic Lymphocytic Leukemia (CLL).

Characteristics of Patients with Stage I Follicular Lymphoma (FL) Selected for Watchful Waiting (WW) in the US: Report from the National LymphoCare Study (NLCS).

AML with 11q23/ MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases

Rebuttal to Ajioka and Kushner

Hodgkin’s Disease : Mortality in the United States, 1921-1951; Race, Sex and Age Distribution; Comparison with Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only